Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
Clinical trial NCT05153772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05153772
- Sponsor
- Orano Med LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2025-04-14
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.